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Abstract: In Switzerland a rapid increase in the total overweight population (BMI ≥ 25) 
from  30.3%  to  37.3%  and  in  the  obese  segment  (BMI  ≥  30)  from  5.4%  to  8.1%  was 
observed between 1992 and 2007. The objective of this study is to produce a projection until 
2022 for the development of adult overweight and obesity in Switzerland based on four 
National Health Surveys conducted between 1992 and 2007. Based on the projection, these 
prevalence rates may be expected to stabilize until 2022 at the 2007 level. These results 
were compared with future projections estimated for France, UK, US and Australia using 
the same model.  
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1. Introduction 
Obesity  is  a  chronic  disease  whose  prevalence  has  been  described  as  reaching  ―epidemic‖ 
proportions around the world [1,2]. Obesity is associated with a high risk of morbidity, mortality as 
well as reduced life expectancy [3]. The major health consequences of overweight and obesity are  
type 2 diabetes mellitus, all cancers except esophageal (female), pancreatic and prostate cancer, all 
cardiovascular diseases (except congestive heart failure), asthma, gallbladder disease, osteoarthritis 
and chronic back pain [4]. 
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Particularly worrisome is the fact that among European school-age children (as an indicator of 
trends among older children and, eventually, adults in the decades to come), the prevalence rates of 
overweight are not only rising but also apparently accelerating [5]. It is most alarming that the current 
prevalence rate of childhood obesity in Europe and North America is more than 10 times higher than 
that  of  the  1970s.  By  2010  it  is  estimated  that  26  million  children  in  the  EU  countries  will  be 
overweight, including 6.4 million who will be obese [6]. 
Switzerland is no exception among other European countries. Data from the fourth National Health 
Survey conducted by the Swiss Federal Institute of Statistics in 2007 showed that the prevalence of 
obesity in the general adult population, defined as body mass index (BMI) ≥ 30, had increased by 2.7% 
points to 8.1% since the first National Health Survey from 1992/93 [7]. For the entire adult Swiss 
population with BMI ≥ 25, a prevalence of 37.3% was observed in 2007 [8]. 
The goal of the present study is to address the question whether the observed alarming trend over 
the past 15 years may be expected to continue over the upcoming 15 years. Thus, a forecast until 2022 
in the development of adult overweight and obesity in Switzerland was conducted through modeling 
based on the four National Health Surveys. For comparison, this model was also applied to other 
European countries (France, UK) as well as to the US and Australia.  
2. Methods and Procedures 
Our trend analyses were based on prevalence data from the Swiss National Health Surveys first 
instituted in 1992/3 and carried out by the Swiss Ministry of Statistics (Bundesamt fü r Statistik (BFS)) 
in 5 years intervals (see Table 1). The National Health Surveys of Switzerland are a series of phone 
surveys executed as part of an overall program of surveys commissioned by the Swiss Ministry of 
Health, i.e., the Bundesamt fü r Gesundheit (BAG) designed to collect information on various health 
aspects of the adult Swiss population (age > 15 years) from a nationally representative sample by 
repeated use of the same questionnaire over time. 
Target  populations:  In  this  study  overweight  and  obesity  populations  were  defined  via  BMI: 
overweight from 25–29.9 kg/m
2, overweight and obesity as BMI ≥ 25, and obesity as BMI ≥ 30 kg/m
2. 
Data sources used for trend projections: 
Switzerland:  Previously  published  prevalence  data  on  overweight  and  obesity  of  the  Swiss 
population (age < 15 years) from the first three National Health Surveys (self-reported data) conducted 
in 1992/3, 1997 and 2002 were used in our trend analysis [7]. Furthermore, prevalence data from the 
fourth Health Surveys conducted in 2007 were available [8]. An additional data set refers to rates of 
overweight and obesity separated for young men and women of 15–24 years old. 
Other countries: The prevalence data for overweight and obesity for the comparing countries—
France, UK, USA (National Health Interview Survey, NIHS) and Australia—were obtained from the 
recently  published  OECD  (Organization  for  Economic  Co-operation  and  Development)  Health 
Working Paper No. 45, which reported on the obesity epidemic in selected OECD countries [9]. All 
data provided in this report refer to rates of overweight and obesity separated for men and women aged 
15–64 years old. With the exception of the UK (health examination survey), all data collections were 
based on National Health Interview Surveys [9].The former provides information on measured BMI, 
while the latter present self-reported figures. Int. J. Environ. Res. Public Health 2010, 7                 
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Statistical  analysis: The most natural  model function for proportions  is  the logistic function as 
displayed in Equation (1) 
p = A / (1 + EXP( B + C * Year) ) ,  (1) 
where p is the proportion of population and A, B and C are parameters to be determined. Equation (1) 
represents a sigmoid curve starting at 0 or 0% in earlier years and going towards A in the future. The 
maximum  of  A  is  1,  corresponding  to  100%.  Depending  on  the  number  of  parameters  used,  we 
distinguish between the 2-parametric (with a fixed value for A) and the 3-parametric logistic function 
(where A is estimated together with parameters B and C). Using A as a fixed  parameter we can 
estimate the parameters B and C by linearizing Equation (1) to 
log(A/p – 1) = B + C * Year  (2)  
and  use  the  estimated  intercept  (B)  and  slope  (C)  as  start  values  for  the  non-linear  model  of  
Equation  (1).  For  the  fixed  value  of  A  in  the  linear  model,  we  used  the  1.2-fold  of  the  largest 
proportion p of the data (except for the obesity data of Australia: an A value of 0.3 was used). The 
assumption behind using an estimate of A below 1 is that never are all people either overweight or 
obese. These estimated parameters A, B and C are then used in the 3-parametric non-linear regression 
as  start  values  for  the  curve  fitting  process.  In  case  the  3-parametric  logistic  regression  did  not 
converge, we used the 2-parametric logistic regression model using A = 1. In order to assure that the 
data points were not in the asymptotic part of the S-shaped regression line, the descriptor variable Year 
was centralized before its use in the statistical model equation. Obvious outliers, most probably due to 
a biased population of the surveys, were eliminated as indicated in Table 2. 
Equation (1) with the estimated parameters was then used to predict the proportion p for the year 
2022. The uncertainty of this prediction is quite large. It becomes larger with increasing distance from 
the closest measured point, the smaller the number of actual measurements and the higher the spread 
around the fitted line. In addition, the predictions are more reliable if the measuring points are located 
in the upper part of the S-shaped curve. Curves and predictions for the intermediate BMI segment 
between 25 and 30 are calculated as the difference between the BMI ≥ 25 and BMI ≥ 30 curve values. 
The results presented show the expected proportions of the populations of the various countries 
analyzed that will be overweight or obese in 2022. The obtained prevalence rates were plotted as  
non-linear curves. The parameters A, B and C of these curves are given in Table 2. SAS
® statistical 
software version 9.2 and R version 2.8.1 (R Development Core Team (2008)) were used. 
3. Results and Discussion  
3.1. Observed Prevalence of Overweight and Obesity in Switzerland from 1992 to 2007 
Total  population:  All  estimates  are  based  upon  prevalence  data  from  the  four  National  Health 
Surveys (telephone surveys) conducted by the Swiss Ministry of Statistics (Bundesamt fü r Statistik 
(BFS)) between 1992 and 2007 [7,8,10,11]. The development of overweight and obesity (BMI ≥ 25) 
over the period between 1992 and 2007 is shown in Table 1 and summarized in Figure 1, which clearly 
shows that the part of the adult population with surplus weight increased by 7% over these 15 years. 
This development is particularly obvious in the male population (increase by 7.2%), whereas it appears Int. J. Environ. Res. Public Health 2010, 7                 
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that a steady state may have been reached in the female population in this period (minimal increase  
of 0.4%). 
Age segment 15–24: The actual development of the overweight prevalence over the past 15 years in 
the youngest segment of the adult Swiss population, i.e., the age group between 15 and 24 years, is 
considered indicative for the trend in future development of the entire overweight segment. For this 
reason we analyzed this population segment separately. 
As shown in Table 1, the population with BMI ≥ 25 in this age segment increased by 1.9% from 
1992 to 2007. The increase in overweight individuals (BMI 25–29.9) amounted to 1% and the obese 
population (BMI ≥ 30) grew by 0.9%. The male part of the young adult population is predominantly 
responsible for this increase, whereas the female segment may have entered a steady state after the 
peak in 1997. 
Table 1. Results of the Swiss National Health Surveys from 1992 to 2007 [7,8,11,12]. 
Nat.  
survey 
Total adult population (age >15) 
Overweight & obesity  Overweight  Obesity 
BMI  25  BMI 25 - 29.9  BMI  30 
  Female  male  total   female  male  total   female  male  total   female  male  total  
  total number  total number  total number  %  %  %  %  %  %  %  %  % 
1992/93  2 947 789  2 735 471  5 683 260  21.8  39.2  30.3  17.1  33.1  24.9  4.7  6.1  5.4 
1997  3 052 211  2 827 975  5 880 186  28.2  42.2  34.9  21.2  35.5  28.1  7.0  6.7  6.8 
2002  3 108 453  2 909 185  6 017 638  29.3  45.4  37.1  21.8  37.5  29.4  7.5  7.9  7.7 
2007  3 164 763  3 021 948  6 186 711  28.6  46.4  37.3  20.9  37.8  29.2  7.7  8.6  8.1 
 
Total population (age 15–24) 
Overweight & obesity  Overweight  Obesity 
  BMI  25  BMI 25 - 29.9  BMI  30 
  female  male  total   female  male  total   female  male  total   female  male  total  
  total number  total number  total number  %  %  %  %  %  %  %  %  % 
1992/93  423 107  432 646  855 752  6.8  12.9  9.8  6.1  11.8  8.9  0.7  1.1  0.9 
1997  400 874  406 866  807 739  9.4  11.9  10.5  8.4  10.8  9.6  0.8  1.1  0.9 
2002  414 663  430 144  844 807  7.9  14.3  11.2  5.4  12.7  9.1  2.5  1.6  2.1 
2007  458 298  486 648  944 947  7.7  15.4  11.7  6.0  13.6  9.9  1.7  1.8  1.8 
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Figure 1. Prevalence of overweight (o), obesity (Δ) and overweight & obesity (x) among 
Swiss adults (age > 15): observed during 1992/93–2007 and projected (solid lines) up to 
2022.  The  projected  prevalence  rates  presented  here  are  those  based  on  our  logistic 
regression estimation. a) Total adult, b) total adult men, c) total adult women. 
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3.2. Projected Prevalence of Overweight and Obesity in Switzerland from 2007 to 2022 
 
Total population: The above described data from the four available Swiss Health Surveys were used 
to model future trends for the development of obesity and overweight prevalence rates in the adult 
Swiss population until 2022. The expected proportions of adult Swiss population that are estimated to 
be overweight and obese by 2022 are shown in Figure 1. 
The projection until 2022 yields an estimated minimal increase to 37.7% (from 37.3%) in the adult 
Swiss population with BMI ≥ 25, indicating a stabilization compared to the preceding 15 years period 
at  a  level  below  40%  (Figure  1a  and  Table  2a).  The  corresponding  prevalence  in  2022  in  the 
population segment with BMI 25–29.9 is expected to be around 29.3%, a marginal increase by 0.1% 
from 2007. The projected small increase in prevalence from 8.1% in 2007 to 8.4% in 2022 in the obese 
population  segment  (BMI  ≥  30)  underscores  the  likelihood  that  the  increase  in  the  obese  Swiss 
population may come to a virtual halt in the upcoming two decades. 
In the adult Swiss male population with BMI ≥ 25, the projected development shows a slow down 
in  the  anticipated  increase  to  reach  an  approximate  prevalence  of  48.7%  from  46.4%  in  2007  
(Figure  1b).  The  expected  prevalence  in  2022  in  the  male  overweight  segment  (BMI  25–29.9)  
of  around  37.4%,  down  from  37.8%  in  2007,  confirms  the  projected  levelling  out  in  the  male 
overweight population.  
A  potential  prevalence  of  28.9%  by  2022  can  also  be  expected  for  the  adult  female  Swiss 
population  with  BMI  ≥  25,  compared  to  28.6%  in  2007,  indicating  a  stable  situation  (Figure  1c,  
Table 2a). Similarly, the female overweight segment (BMI 25–29.9) is expected to be around 21.2% in 
2022,  virtually  unchanged  to  2007  (20.9%)  and  the  prevalence  in  the  obese  female  segment  
(BMI ≥ 30) is anticipated to remain at 7.7%. 
Age segment 15–24: The projection of the assumed prevalence in 2022 anticipates an increase to 
12.8% (from 11.7% in 2007) in the young adult population with BMI ≥ 25 (Table 2a). The prevalence 
is expected to decrease to 8.5% by 2022 from 9.9% in 2007 in the overweight segment (BMI 25–29.9), 
whereas the prevalence in the obese segment (BMI ≥ 30) may eventually increase to 4.3% from 1.8% 
in 2007 (Table 2b). 
3.3. Projected Prevalence of Overweight and Obesity from 2007 to 2022 in Other Countries 
The use of non-linear logistic regressions  described above provides a more accurate picture of 
overweight and obesity trends over time within a country than linear trend estimation. This approach 
may also be more useful to compare future trends across countries, provided that sufficient data from 
repeated cross-sectional national surveys over longer time periods are available. 
Recently published data available from repeated cross-sectional national surveys from France, UK, 
US (NHIS) and Australia [9] allowed the projection of the development of overweight and obesity 
prevalence until 2022 using our logistic curve fitting model. As shown in Figure 3a, the development 
of overweight prevalence (BMI ≥ 25) of the adult population in the two central European countries—
Switzerland and France—over the past years was comparable and is expected to reach around 40% 
until 2022 in both countries (Table 2a). An overlapping development in overweight prevalence has 
been observed between 1990 and 2005 in the UK and the US, reaching a significantly higher level Int. J. Environ. Res. Public Health 2010, 7                 
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(around 60%) than in central Europe. Future projections anticipate a levelling out above the 60% mark 
by 2022. In Australia, an almost linear increase in overweight prevalence was observed from 1989 
until 2004 and the trend analysis foresees a continued increase to a level of about 65% in 2022. 
In Figure 3b the corresponding developments for the prevalence of obesity in the five countries are 
shown. Switzerland and France show a comparable development since 1990 until present, reaching 
obesity  prevalence  rates  around  8%–9%.  In  the  case  of  Switzerland,  trend  analysis  indicates 
stabilization over the next 15 years whereas a continued increase may be expected to occur in France 
up to a prevalence of about 17% in 2022. For the UK and the US, the projections predict a continued 
increase in obesity prevalence in both countries eventually reaching a level around 30% (Table 2b). In 
Australia, a continued increase up to approximately 25% may be expected until 2022. 
Table 2a. Logistic regression results for overweight (BMI ≥ 25): Model parameters A, B 
and C of Equation 1. If parameter A = 1 then the 2-parameter model was used. n = number 
of survey years. 
Country  Population  Age (y) 
Outlier 
excluded 
n  A  B  C 
Pred. 
2022 
Australia  Total  >15    4  0.7535  125.1  −0.0629  66.6% 
  Men  >15    4  0.9926  102.0  −0.0512  80.5% 
  Women  >15    4  0.5769  151.0  −0.0759  53.5% 
France  Total  >15  1996,0.349  11  0.5494  72.3  −0.0364  42.4% 
  Men  >15  1996,0.426  11  0.4775  155.3  −0.0785  46.2% 
  Women  >15  1996,0.283  11  1  45.1  −0.0221  36.5% 
Switzerland  Total  >15    4  0.3774  459.9  −0.2316  37.7% 
  Men  >15    4  0.4936  195.3  −0.0987  48.7% 
  Women  >15    4  0.2890  1050.6  −0.5280  28.9% 
Switzerland  Total  15–24    4  0.1385  108.1  −0.0547  12.8% 
  Men  15–24    4  1  36.4  −0.0173  18.8% 
  Women  15–24    4  1  9.7  −0.0036  8.5% 
UK  Total  >15  2002,0.503  13  0.6197  317.1  −0.1598  61.8% 
  Men  >15  2002,0.532  14  0.6610  385.6  −0.1943  66.1% 
  Women  >15  2002,0.479  14  0.5983  249.7  −0.1259  59.3% 
US NHIS  Total  >15    9  0.6321  264.4  −0.1332  62.8% 
  Men  >15    9  0.7023  336.6  −0.1696  70.1% 
  Women  >15    9  0.5968  177.4  −0.0894  57.7% 
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Table 2b. Logistic regression results for obesity (BMI ≥ 30): Model parameters A, B and 
C of Equation 1. If parameter A = 1 then the 2-parameter model was used.  
Country  Population  Age (y) 
Outlier 
excluded 
n  A  B  C 
Pred. 
2022 
Australia  Total  >15    4  0.2778  193.8  −0.0970  25.4% 
  Men  >15    4  0.6587  138.8  −0.0688  38.4% 
  Women  >15    4  0.2063  254.5  −0.1278  20.2% 
France  Total  >15  1996,0.091  11  1  83.3  −0.0404  16.9% 
  Men  >15  1996,0.089  11  1  83.0  −0.0403  16.9% 
  Women  >15  1996,0.093  11  1  83.8  −0.0407  17.0% 
Switzerland  Total  >15    4  0.0847  340.2  −0.1711  8.4% 
  Men  >15    4  0.1800  81.1  −0.0404  11.3% 
  Women  >15    4  0.0768  737.0  −0.3702  7.7% 
Switzerland  Total  15−24    4  1  108.5  −0.0521  4.3% 
  Men  15−24    4  1  81.3  −0.0385  3.2% 
  Women  15−24    4  0.0212  707.2  −0.3543  2.1% 
UK  Total  >15  2002,0.186  14  0.3245  183.6  −0.0920  30.0% 
  Men  >15    15  0.2780  228.3  −0.1145  26.8% 
  Women  >15  2002,0.192  14  0.4630  119.1  −0.0594  34.7% 
US NHIS  Total  >15    9  0.3082  238.8  −0.1198  29.9% 
  Men  >15    9  0.2910  293.7  −0.1474  28.7% 
  Women  >15    9  0.3253  202.1  −0.1014  30.9% 
   
Figure 2. Prevalence of overweight (BMI ≥ 25) and obesity (BMI ≥ 30) among the adult 
populations (>15) of the US (NHIS), UK, Australia, France and Switzerland: observed 
from 1989–2007 and projected (solid lines) up to 2022. The projected prevalence rates 
presented here are those based on our logistic regression estimation.  
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4. Discussion  
As reported by the International Association for the Study of Obesity (IASO), the prevalence of 
obesity  as  defined  by  BMI  ≥  30  has  surpassed  the  20%  population  mark  in  many  European  
countries [12]. As a consequence, overweight and obesity are frequently making media headlines and 
are amongst the highest priority public health issues in the world [13]. To make matters worse, current 
evidence suggests that the prevalence of overweight and obesity is likely to remain on the rise in the 
US [14], developing countries [15] as well as Europe [16]. Taking this worldwide development in 
obesity into account, one central question arises: When will this global trend of increasing overweight 
and obesity come to an end?  
The  present  study  aimed  at  providing  a  possible  answer  to  this  question  with  respect  to  the 
overweight  and  obesity  situation  in  Switzerland.  Between  1992  and  2007  a  rapid  and  significant 
increase  in  the  prevalence  of  overweight  and  obesity  (BMI  ≥  25)  in  the  adult  Swiss  population  
(age > 15) by 7% to a total of 37.3% was observed, consisting of a predominant increase in the 
proportion of overweight individuals (BMI 25–30) by 4.3% and a concomitant increase of the obese 
population by 2.7%.  
The projection until 2022 based on the above prevalence data by a logistic regression model offers 
an estimated minimal increase to 37.7% in the prevalence of the overweight and obese segment of the 
Swiss population (BMI ≥ 25), indicating stabilization at a plateau below 40%. This interpretation is 
supported by trend analysis of the youngest segment (age 15–24) of the adult overweight and obese 
population with BMI ≥ 25, as the projection of the assumed prevalence in 2022 shows only a small 
increase by 1.1%. Regarding the expected obesity prevalence in 2022, the projected value is 8.4% in 
the entire Swiss population, a slight increase by 0.3% compared to 2007, again indicating stabilization 
at a level below 10%. Although the projected value for 2022 in the youngest population segment  
(age 15–24) increases to 4.3% from 1.8% in 2007, it does not necessarily contradict the trend towards 
stabilization expected in the entire Swiss population. It has to be kept in mind that the projection in the 
young obese population segment is based upon a small number of individuals with a corresponding 
high degree of uncertainty. 
Our prediction for the expected development of overweight and obesity in Switzerland is not as 
grim as a recent projection for the US, which forecasts that, by 2048, all American adults would 
become overweight or obese, while black women will reach this state by 2034 [17]. In the context of 
this gloomy projection for the US population, it has to be mentioned that for this US projections a 
linear regression model was used to extrapolate future prevalence rates. Obviously, a simple linear 
model for proportional data is only appropriate in the approximately linear region of the S-shaped 
curve and does not allow projections in the asymptotic part of the curve. Using a logistic regression 
model approach with a 3-parameter logistic function, however, not only accounts for the slowdown of 
the rates at both ends of the curve but also allows the overweight population to reach a limit below 
100% (parameter A < 1), while attaining a close match to the data already available. Thus, using the 
US-NHIS data in our model, the US overweight prevalence rate is projected to level out until 2022 
around 63% from 59.3% in 2005. The same levelling of the US obesity trend was found in projections 
produced in 2006 by the Centers of Disease Control and Prevention [18]. Furthermore, our findings 
were recently confirmed in the context of a study projecting the future diabetes population in the US Int. J. Environ. Res. Public Health 2010, 7                 
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and describing that the overall distribution in the non-diabetic population remains fairly stable with 
~65% being overweight or obese [19]. Interestingly, the curve obtained from the UK prevalence data 
between 1991 and 2005 is virtually matching the US prevalence curve (Figure 2a). A similar overlap 
of obesity prevalence curves, both observed and projected, between the US and the UK results from 
our model approach indicates that the situation in the past and the future appears to be comparable 
between these two countries (Figure 2b). A similar development in overweight and obesity prevalence 
has also been observed in 1990–2007 between Switzerland and France, but at lower levels than in the 
US and the UK. The projections predict a levelling out for overweight until 2022 in both countries 
eventually reaching a level between 38% and 42%, compared to approximately 63% in the US and the 
UK. While the obesity prevalence in France may increase to about 17%, the situation in Switzerland is 
expected to remain stable (8.4%), less than a third of the obesity prevalence projected for the US and 
the UK. The most rapid increase in overweight prevalence over time has been experienced in Australia 
(Figure 2a). Trend analysis results in the highest expected overweight prevalence for all five countries 
evaluated to about 65% in 2022. In support of our findings, similar projected trends regarding France, 
US, UK and Australia have been described in the recently published OECD working paper [9]. 
An interesting finding of the present study refers to the obvious differences in overweight and 
obesity prevalence rates observed between the evaluated countries, particularly between Switzerland 
and France on one side and the US, UK and Australia on the other. Unfortunately, there is no simple 
explanation for the observed, obvious differences between these industrialized countries. It may be 
speculated that differences in the obesogenic environments (aspects of physical, social and economic 
environments that favour obesity development) exist between the US, UK and Australia and the two 
central European countries that could be responsible for the observed differences in overweight and 
obesity prevalence rates developed over time. It has been argued that obesity represents a life-style 
situation heavily influenced by genetic heritage [20]. Genetics alone, however, cannot account for the 
increase in overweight and obesity encountered in many countries over the past 2–3 decades [9]. 
Although  socioeconomic  difference  in  obesity  prevalence  rates  are  well  documented,  in  countries 
where the largest socioeconomic disparities exist, overweight and obesity rates are not necessarily the 
highest  [9].  Overweight  and  obesity  may  also  be  viewed  as  environmental  (social)  phenomena 
promoting physical inactivity and excessive food consumption [21]. Research showed that the spread 
of obesity in social networks (family, peer groups) appears to be another important factor in the global 
obesity epidemic [22]. In summary, it appears that obesogenic environments that promote physical 
inactivity  and  excess  (fat)  food  consumption  may  have  encouraged  individuals,  particularly  when 
socially and culturally vulnerable, to chose/accept less healthy life styles, and those with a genetic 
predisposition may have ended up becoming overweight and obese [9]. Differences in overweight and 
obesity  among  individuals  with  different  levels  of  education  are  remarkably  consistent  across 
countries. In most countries a gradient is observed: the lower the education attainment, the higher the 
likelihood of being obese or overweight [9]. Switzerland is no exception as the obesity prevalence also 
decreases with higher educational level in both genders [22]. The fact that obesity and overweight are 
higher  among  men  and  women  with  lower  educational  attainment  does  not  explain  the  observed 
differences in overweight and obesity prevalence rates developed over time between the US, UK and 
Australia on one hand, and France and Switzerland on the other hand. Int. J. Environ. Res. Public Health 2010, 7                 
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Our study has several limitations. The major limitation is the fact that the model used for our 
projections is based on a number of assumptions. We assume that it is highly unlikely that the entire 
population of a specific country may turn overweight or obese. Thus, we calculated an upper limit for 
both cases based on presently available prevalence data, assuming that the upper asymptotic part of the 
S-shaped curve comes to lie below 100% (parameter A < 1) as a close reflection of the real situation. 
Future observations may disprove these assumptions. Furthermore, the estimation of the prevalence 
rates may not be absolutely comparable in the five countries evaluated since the methods of estimation 
differed among the countries (surveys vs. actual measurements) [24,25]. For example, from the two 
different  surveys  undertaken  in  the  US,  the  National  Health  and  Nutrition  Examination  Survey 
(NHANES) and the National Health Interview Survey (NHIS), the former provides information on 
measured  BMI,  while  the  latter  presents  self-reported  figures.  Self-reported  rates  from  the  NHIS 
appear to under-estimate obesity compared to actual rates reported in NHANES, but the time trends 
are the same [9]. 
In conclusion, after a rapid increase in the total overweight population (BMI ≥ 25) as well as in the 
obese population segment (BMI ≥ 30) in Switzerland over the past 15 years, the prevalence rates may 
be expected to basically stabilize between 2007 and 2022 at about the 2007 level. In all four countries 
(France, US, UK, Australia) with nationally representative data collections over the past 1–2 decades 
evaluated  for  comparative  reasons,  a  rapid  increase  in  the  prevalence  of  overweight  and  obesity 
occurred during the last 10–20 years. While the development in France, compared to Switzerland, 
showed a similar increase in overweight and obesity over a comparable time period, the other countries 
(US, UK, Australia) reached considerably higher proportions in the overweight and obese segments of 
the  adult  population.  The  projection  based  on  the  presently  available  overweight  and  obesity 
prevalence data using logistic regression analysis yielded a levelling off with respect to the expected 
overweight  prevalence  rates  in  Switzerland,  France,  the  US  and  the  UK  until  2022,  whereas  a 
continuous increase in overweight is expected to occur in Australia. Based on this projection it appears 
that the unprecedented increase in overweight prevalence in some industrialized countries may come to 
an  end  in  the  next  decade.  With  the  exception  of  Switzerland,  obesity  prevalence  rates  are  still 
expected to rise until 2022 albeit at a slower pace. Countries with a historically ―low‖ obesity level, 
such  as  Switzerland  and  France,  may  not  catch  up  to  the  countries  with  much  higher  obesity 
prevalence  rates  (US,  UK,  Australia)  within  the  upcoming  decades  for  reasons  unknown  at  the  
present time. 
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